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Introduction
CMR perfusion (CMRP) imaging using adenosine is
increasingly used for the assessment of patients with
known or suspected coronary artery disease. At a standard
dose adenosine is well tolerated with a good safety profile
but on occasion fails to produce a significant haemody-
namic response. This may potentially lead to the misdiag-
nosis of significant ischaemia. We therefore examined
whether using a higher dose in these patients to induce a
haemodynamic response would lead to the identification
of additional perfusion defects.
Methods
We prospectively recruited from 1230 consecutive
patients undergoing CMRP. First pass CMRP was per-
formed on a Philips Achieva CV 1.5 T MR scanner
(Philips, The Netherlands), with standardised acquisition
protocol with standard dose adenosine (SDA) at 140 µg/
kg/min for 3 minutes. 3 short axis slices of 10 mm thick-
ness were acquired per cardiac cycle using a single shot
prospectively gated balanced TFE sequence (TR 2.5 ms, TE
1.3 ms, Flip angle 50° and voxel size 2.8 × 2.8 mm2) after
the administration of a 0.1 mmol/Kg bolus of intravenous
Gadolinium. Heart rate (HR) and blood pressure (BP)
were recorded at baseline and during stress. Non respond-
ers were defined as those patients with a normal CMRP
scan and blunted haemodynamic response (maximum
HR increase <10 beats per minute and fall in systolic BP
(SBP) <10 mmHg). CMRP in this group was then repeated
with high dose adenosine (HDA) at 175 µg/kg/min for 3
minutes. CMRP images were interpreted by 2 independ-
ent experienced observers. Coronary angiographic data
was analysed by an experienced interventionist who was
blinded to the perfusion data. Results obtained at SDA
and HDA (expressed as mean value value ± SD) were com-
pared using the student t test.
Results
Table 1, 51 patients (4.1%) recieved HDA. HDA was well
tolerated with no serious adverse events. Coronary angio-
graphic data was available for 20 patients (39%). HDA
stress resulted in a significant increase in HR and RPP in
non responders (Table 2). CMRP with HDA identified
perfusion defects in 12 patients (24%) which were not
present following stress with SDA. In 11 patients (92%)
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Table 1: Patient characteristics (n = 51)
Characteristic Number (%)






Known coronary artery disease 19 (54%)Page 1 of 2
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the identified perfusion defects correlated with significant
stenosis (>70%) on the angiogram.
Conclusion
HDA achieved significant haemodynamic end-points
with no significant clinical adverse events. Additional per-
fusion defects in the non responders at SDA were found
using HDA. The perfusion defects correlated with signifi-
cant coronary stenoses. The use of HDA may be important
in certain patients where there is little or no haemody-
namic response to SDA.
Table 2: Haemodynamic response to adenosine stress (n = 51)
Rest Standard dose High dose
Systolic BP (mmHg) 136 ± 19 137 ± 23 133 ± 23
Heart rate (bpm) 68 ± 14 72 ± 16 82 ± 17 (P < 0.01)
Rate pressure product (bpm × mmHg/1000) 9.24 ± 2.4 9.89 ± 2.8 10.9 ± 2.5 (P < 0.01)Page 2 of 2
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